Evaluation on Visual Outcome of TMS
ConditionVisual Impairment
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-80
SponsorEvidence Based Cataract Study Group
About this trial
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients with visual impairment. The main question it aims to answer is:
• Does TMS improve the visual outcome in patients who suffer from visual impairment? Researchers will compare TMS to the control group who will not receive effective TMS treatment) to see if TMS works to improve the visual outcomes of the patients.
Participants will
* Undergo TMS treatment or no effective TMS for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.
Eligibility criteria
Qualifiers
Post cataract surgery or clear lens
Best-corrected visual acuity less than 0.1logMAR
Disqualifiers
Diagnosed with cognitive impairment or mental disorders and unable to cooperate with treatment;
Diagnosed with ocular diseases that affect observation of visual function;
History of epileptic seizures;
Long term use of psychotropic drugs；
Trial design
Treatments tested in this trial
- TMS
- Control
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov